National Heart, Lung, and Blood Institute; Notice of Closed Meeting, 37957-37958 [2020-13550]

Download as PDF Federal Register / Vol. 85, No. 122 / Wednesday, June 24, 2020 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; To review Support of Competitive Research (SCORE) Program Applications. Date: July 15, 2020. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Lisa A. Dunbar, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN12, Bethesda, MD 20892, (301) 594–2849, dunbarl@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: June 18, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–13553 Filed 6–23–20; 8:45 am] jbell on DSKJLSW7X2PROD with NOTICES BILLING CODE 4140–01–P VerDate Sep<11>2014 18:20 Jun 23, 2020 Jkt 250001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; T1D NIDDK Review. Date: July 23, 2020. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Elena Sanovich, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, (301) 594–8886, sanoviche@mail.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; NIDDK Clinical Trials. Date: July 30, 2020. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Elena Sanovich, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, (301) 594–8886, sanoviche@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) PO 00000 Frm 00138 Fmt 4703 Sfmt 4703 37957 Dated: June 18, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–13552 Filed 6–23–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, Member Conflict: Myocardial Ischemia and Metabolism, July 15, 2020, 01:00 p.m. to July 15, 2020, 04:00 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on June 15, 2020, 85 FR 36223. This notice is being amended to change the meeting from Center for Scientific Review Special Emphasis Panel; Member Conflict: Myocardial Ischemia and Metabolism to Center for Scientific Review Special Emphasis Panel; Member Conflict: Cardiovascular Sciences. Meeting dates, time, and location remain the same. The meeting is closed to the public. Dated: June 18, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–13545 Filed 6–23–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\24JNN1.SGM 24JNN1 37958 Federal Register / Vol. 85, No. 122 / Wednesday, June 24, 2020 / Notices Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Pathway to Independence in Blood Science (K99). Date: July 30, 2020. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 1, 6705 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National, Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 208– Z, Bethesda, MD 20892, (301) 827–7987, susan.sunnarborg@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: June 18, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–13550 Filed 6–23–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting jbell on DSKJLSW7X2PROD with NOTICES Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, July 17, 2020, 8:00 a.m. to July 17, 2020, 5:00 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on June 17, 2020, 85 FR 36605. This notice is being amended to change the meeting time from 8:00 a.m.– 5:00 p.m. to 12:00 p.m.–5:00 p.m. The meeting date and location remain the same. The meeting is closed to the public. Dated: June 18, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–13548 Filed 6–23–20; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:20 Jun 23, 2020 Jkt 250001 DEPARTMENT OF HOMELAND SECURITY Transportation Security Administration [Docket No. TSA–2020–0001] Public Meeting and Extension of Comment Period on Request for Information: Air Cargo Security Options To Mitigate Costs of Compliance With International Security Requirements Transportation Security Administration, DHS. ACTION: Notice of public meeting and extension of comment period. AGENCY: On April 10, 2020, TSA published a request for information (RFI) specifically requesting information from the air cargo industry (including manufacturers, shippers, suppliers, warehouses, e-commerce fulfillment centers, third-party logistics providers, and air carriers) relating to compliance with international security standards for the transport of air cargo by commercial aircraft operators (85 FR 20234). In advance of the closing date for comments submitted in response to the RFI, TSA will hold a public meeting on July 29, 2020, to answer questions regarding the international standards discussed in the RFI and to provide an additional forum for comments by stakeholders and other interested persons regarding the issues identified in the RFI. In light of the current COVID–19 public health crisis, the public meeting will be virtual. TSA is also extending the comment period for the RFI to provide an additional period for comments to be submitted after the public meeting. DATES: Virtual public meeting: The virtual public meeting will be on July 29, 2020, via telecom, beginning at 10:00 a.m. (EDT). Comments on request for information: The comment period on the RFI is extended from July 9, 2020, to August 27, 2020. ADDRESSES: To access the public meeting, interested persons should contact the individual in the FOR FURTHER INFORMATION CONTACT section to receive the telephone number and participant code. Participants should call 2–7 minutes in advance to avoid overloading the phone servers. Persons unable to join public meeting may submit comments to the RFI published on April 10, 2020 (85 FR 20234). FOR FURTHER INFORMATION CONTACT: Thomas Friedman, Transportation Security Administration, 601 South SUMMARY: PO 00000 Frm 00139 Fmt 4703 Sfmt 4703 12th Street, Arlington, VA 20598–6028; telephone (571) 227–3555 OR (202) 236–3786; email Thomas.Friedman@ tsa.dhs.gov OR Air Cargo Branch, TSA at the above address. SUPPLEMENTARY INFORMATION: Availability of Committee Documents You may obtain an electronic copy of the record for the public meeting or other submissions related to this action by using the internet through one of the following methods— (1) Search the electronic Federal Docket Management System (FDMS) web page at https://www.regulations.gov; or (2) Access the Government Publishing Office’s web page at https:// www.gpo.gov/fdsys/browse/collection. action?collectionCode=FR to view the daily published Federal Register edition; or accessing the ‘‘Search the Federal Register by Citation’’ in the ‘‘Related Resources’’ column on the left, if you need to do a Simple or Advanced search for information, such as a type of document that crosses multiple agencies or dates. In addition, copies are available by writing or calling the individual in the FOR FURTHER INFORMATION CONTACT section. Make sure to identify the docket number of this action. Comments Invited TSA invites interested persons to participate in this public meeting by participating in the telecom, as listed above. Individuals unable to participate in the public meeting may submit written comments, data, or views by August 27, 2020, following instructions provided in the RFI published on April 10, 2020. See 85 FR 20234. Handling of Confidential or Proprietary Information and Sensitive Security Information (SSI) Submitted in Public Comments Whether participating in the public meeting or submitting comments to the docket, do not submit comments or provide information that includes trade secrets, confidential commercial or financial information, or SSI. Please submit such comments separately from other comments on the action. Comments containing this type of information should be appropriately marked as containing such information and submitted by mail to the address listed in FOR FURTHER INFORMATION CONTACT section. TSA will not place comments containing SSI in the public docket and will handle them in accordance with applicable safeguards and restrictions on access. TSA will hold documents E:\FR\FM\24JNN1.SGM 24JNN1

Agencies

[Federal Register Volume 85, Number 122 (Wednesday, June 24, 2020)]
[Notices]
[Pages 37957-37958]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13550]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


[[Page 37958]]


    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Pathway to Independence in Blood Science 
(K99).
    Date: July 30, 2020.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge 1, 6705 
Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific 
Review Officer, Office of Scientific Review/DERA, National, Heart, 
Lung, and Blood Institute, National Institutes of Health, 6705 
Rockledge Drive, Room 208-Z, Bethesda, MD 20892, (301) 827-7987, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: June 18, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-13550 Filed 6-23-20; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.